IgE, mast cells, and eosinophils in atopic dermatitis (Q37830373)

24 August 2017

1 reference

title

IgE, mast cells, and eosinophils in atopic dermatitis (English)

1 reference

24 August 2017

0 references

1

0 references

author name string

Heidi Goodarzi

series ordinal

2

1 reference

PubMed ID

21249468

24 August 2017

Huan-Yuan Chen

series ordinal

3

1 reference

24 August 2017

1 December 2011

1 reference

Clinical Reviews in Allergy & Immunology

24 August 2017

1 reference

24 August 2017

41

1 reference

24 August 2017

3

1 reference

24 August 2017

298-310

1 reference

https://scigraph.springernature.com/pub.10.1007/s12016-011-8252-4

24 August 2017

0 references

cites work

Clinical practice. Atopic dermatitis

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8252-4

Consensus conference on pediatric atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8252-4

Does the severity of atopic dermatitis correlate with serum IgE levels?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8252-4

The natural course of atopic dermatitis from birth to age 7 years and the association with asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8252-4

Correlation between age and allergens in pediatric atopic dermatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8252-4

Development of atopic dermatitis in the DARC birth cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8252-4

The association between early sensitization patterns and subsequent allergic disease. The DARC birth cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8252-4

The prevalence of food hypersensitivity in young adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8252-4

How atopic is atopic dermatitis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8252-4

Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8252-4

Extraordinarily high serum IgE levels and consequences for atopic phenotypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8252-4

IgE antibody responses in young children with atopic dermatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8252-4

Filaggrin in atopic dermatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8252-4

Filaggrin gene defects and risk of developing allergic sensitisation and allergic disorders: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8252-4

Presence of IgE antibodies to staphylococcal exotoxins on the skin of patients with atopic dermatitis. Evidence for a new group of allergens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8252-4

Use of specific IgE in assessing the relevance of fungal and dust mite allergens to atopic dermatitis: a comparison with asthmatic and nonasthmatic control subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8252-4

IgE and IgG antibodies to Malassezia spp. yeast extract in patients with atopic dermatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8252-4

Candida albicans and atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8252-4

The relevance of microbial allergens to the IgE antibody repertoire in atopic and nonatopic eczema

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8252-4

Isolation of cDNAs coding for IgE autoantigens: a link between atopy and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8252-4

Serum IgE autoantibodies target keratinocytes in patients with atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8252-4

Molecular characterization of an autoallergen, Hom s 1, identified by serum IgE from atopic dermatitis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8252-4

Identification of Profilin as a Novel Pollen Allergen; IgE Autoreactivity in Sensitized Individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8252-4

Humoral and cell-mediated autoimmunity in allergy to Aspergillus fumigatus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8252-4

Characterization of IgE-reactive autoantigens in atopic dermatitis. 1. Subcellular distribution and tissue-specific expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8252-4

Immunoglobulin E-bearing antigen-presenting cells in atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8252-4

Effect of combined antibacterial and antifungal treatment in severe atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8252-4

Roles of TH1 and TH2 cytokines in a murine model of allergic dermatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8252-4

Omalizumab-induced reductions in mast cell Fce psilon RI expression and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8252-4

Efficacy of omalizumab in the treatment of atopic dermatitis: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8252-4

Human dermal mast cells contain and release tumor necrosis factor alpha, which induces endothelial leukocyte adhesion molecule 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8252-4

Mast cells enhance T cell activation: Importance of mast cell-derived TNF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8252-4

Mast cell-T cell interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8252-4

Nasal mast cells in perennial allergic rhinitics exhibit increased expression of the Fc epsilonRI, CD40L, IL-4, and IL-13, and can induce IgE synthesis in B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8252-4

Induction of human IgE synthesis in B cells by mast cells and basophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8252-4

Histamine-induced IL-6 and IL-8 production are differentially modulated by IFN-gamma and IL-4 in human keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8252-4

Histamine enhances the production of granulocyte-macrophage colony-stimulating factor via protein kinase Calpha and extracellular signal-regulated kinase in human keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8252-4

IgE-mediated mast cell activation induces Langerhans cell migration in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8252-4

Rat peritoneal mast cells present antigen to a PPD-specific T cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8252-4

Presentation of soluble antigens by mast cells: upregulation by interleukin-4 and granulocyte/macrophage colony-stimulating factor and downregulation by interferon-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8252-4

Mast cells and vasculature in atopic dermatitis--potential stimulus of neoangiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8252-4

Association of atopic dermatitis to the beta subunit of the high affinity immunoglobulin E receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8252-4

Mast cell chymase is increased in chronic atopic dermatitis but not in psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8252-4

A rodent model for allergic dermatitis induced by flea antigens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8252-4

Serum levels of soluble stem cell factor and soluble KIT are elevated in patients with atopic dermatitis and correlate with the disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8252-4

Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8252-4

CCL1-CCR8 Interactions: An Axis Mediating the Recruitment of T Cells and Langerhans-Type Dendritic Cells to Sites of Atopic Skin Inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8252-4

Down-regulation of vasoactive intestinal polypeptide receptor expression in atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8252-4

Mediation of local homeostasis and inflammation by leukotrienes and other mast cell-dependent compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8252-4

Mast cell CD30 ligand is upregulated in cutaneous inflammation and mediates degranulation-independent chemokine secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8252-4

Mast cells in atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8252-4

Expression of interleukin-4 in the epidermis of transgenic mice results in a pruritic inflammatory skin disease: an experimental animal model to study atopic dermatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8252-4

Transgenic expression of interleukin-13 in the skin induces a pruritic dermatitis and skin remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8252-4

IL-4/IL-13 antagonist DNA vaccination successfully suppresses Th2 type chronic dermatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8252-4

RabGEF1 is a negative regulator of mast cell activation and skin inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8252-4

A mouse model of the atopic eczema/dermatitis syndrome by repeated application of a crude extract of house-dust mite Dermatophagoides farinae

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8252-4

Contribution of IL-18 to atopic-dermatitis-like skin inflammation induced by Staphylococcus aureus product in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8252-4

Oral chymase inhibitor SUN13834 ameliorates skin inflammation as well as pruritus in mouse model for atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8252-4

Chymase inhibitor improves dermatitis in NC/Nga mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8252-4

Hyaluronic acid targets CD44 and inhibits FcepsilonRI signaling involving PKCdelta, Rac1, ROS, and MAPK to exert anti-allergic effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8252-4

Effects of dexamethasone on mediator release from human lung fragments and purified human lung mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8252-4

Dexamethasone inhibits maturation, cytokine production and Fc epsilon RI expression of human cord blood-derived mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8252-4

Dexamethasone and FK506 inhibit expression of distinct subsets of chemokines in human mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8252-4

Pimecrolimus in dermatology: atopic dermatitis and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8252-4

Topical calcineurin inhibitors in cutaneous lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8252-4

Reduced dermal infiltration of cytokine-expressing inflammatory cells in atopic dermatitis after short-term topical tacrolimus treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8252-4

Activation of platelets by eosinophil granule proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8252-4

Correlation of eosinophils, eosinophil cationic protein and soluble interleukin-2 receptor with the clinical activity of atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8252-4

Blood eosinophilia in atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8252-4

Peripheral blood eosinophils and IL-4 in infancy in relation to the appearance of allergic disease during the first 6 years of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8252-4

Urinary eosinophil protein X and serum eosinophil cationic protein in infants and young children with atopic dermatitis: correlation with disease activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8252-4

Serum eosinophil cationic protein (ECP) is a sensitive measure for disease activity in atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8252-4

Elevated serum levels of the eosinophil granule major basic protein in patients with eosinophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8252-4

Interleukin-4, -5, and -6 and tumor necrosis factor-alpha in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8252-4

Eosinophils and atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8252-4

Highly purified murine interleukin 5 (IL-5) stimulates eosinophil function and prolongs in vitro survival. IL-5 as an eosinophil chemotactic factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8252-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8252-4

Eotaxins and CCR3 Receptor in Inflammatory and Allergic Skin Diseases: Therapeutical Implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8252-4

Induction of eotaxin production by interleukin-4, interleukin-13 and lipopolysaccharide by nasal fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8252-4

Chemokine-induced eosinophil recruitment. Evidence of a role for endogenous eotaxin in an in vivo allergy model in mouse skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8252-4

RANTES production from mononuclear cells in response to the specific allergen in asthma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8252-4

Increased levels of serum interleukin-16 in adult type atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8252-4

Pathophysiology of atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8252-4

Expression of transforming growth factors-alpha and beta 1 messenger RNA and product by eosinophils in nasal polyps.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8252-4

The Relationship Between Allergen-Induced Tissue Eosinophilia and Markers of Repair and Remodeling in Human Atopic Skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8252-4

Patterns of sensitization in infants and its relation to atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-011-8252-4

Eosinophil major basic protein induces degranulation and IL-8 production by human eosinophils

21 January 2018

1 reference

12 December 2020

Does the tail wag the dog? Role of the barrier in the pathogenesis of inflammatory dermatoses and therapeutic implications

1 reference

12 December 2020

Monitoring of disease activity by measurement of inflammatory markers in atopic dermatitis in childhood

1 reference

12 December 2020

Wanted: A study with omalizumab to determine the role of IgE-mediated pathways in atopic dermatitis

1 reference

12 December 2020

Mast cell degranulation upregulates alpha 6 integrins on epidermal Langerhans cells

1 reference

12 December 2020

Stimulation of basophil and rat mast cell histamine release by eosinophil granule-derived cationic proteins

1 reference

12 December 2020

Urine eosinophil protein X (EPX) is an in vitro parameter of inflammation in atopic dermatitis of the adult age

1 reference

12 December 2020

Human eosinophils produce biologically active IL-12: implications for control of T cell responses.

1 reference

12 December 2020

Mast cells enhance T cell activation: importance of mast cell costimulatory molecules and secreted TNF

1 reference

12 December 2020

Antigen-dependent stimulation by bone marrow-derived mast cells of MHC class II-restricted T cell hybridoma.

1 reference

12 December 2020

Dermal deposition of eosinophil-granule major basic protein in atopic dermatitis. Comparison with onchocerciasis

1 reference

12 December 2020

Prevalence and role of serum IgE antibodies to the Staphylococcus aureus-derived superantigens SEA and SEB in children with atopic dermatitis

1 reference

12 December 2020

Mouse bone marrow-derived mast cells and mast cell lines constitutively produce B cell growth and differentiation activities

1 reference

12 December 2020

Food allergy and atopic dermatitis in infancy: an epidemiologic study

1 reference

12 December 2020

Immunoglobulin E response to human proteins in atopic patients

1 reference

12 December 2020

[Peripheral eosinophil counts relates the improvement of the skin lesions of atopic dermatitis patients more sensitive than serum eosinophil cationic protein levels]

1 reference

12 December 2020

Association between severity of atopic eczema and degree of sensitization to aeroallergens in schoolchildren☆☆☆★

1 reference

12 December 2020

The mast cell mediator PGD2 suppresses IL-12 release by dendritic cells leading to Th2 polarized immune responses in vivo

1 reference

12 December 2020

In vivo expression of IL-12 and IL-13 in atopic dermatitis

1 reference

12 December 2020

Association between genetic variants of mast-cell chymase and eczema

1 reference

12 December 2020

Failure of omalizumab for treatment of severe adult atopic dermatitis

1 reference

12 December 2020

Mast cells process bacterial Ags through a phagocytic route for class I MHC presentation to T cells

1 reference

12 December 2020

Hematopoiesis in mice lacking the entire granulocyte-macrophage colony-stimulating factor/interleukin-3/interleukin-5 functions

1 reference

12 December 2020

Mast cells are one major source of interleukin-4 in atopic dermatitis

1 reference

12 December 2020

Modulation of serum eosinophil cationic protein levels by cyclosporin in severe atopic dermatitis

1 reference

12 December 2020

IgE antibodies to Pityrosporum ovale in atopic dermatitis

1 reference

12 December 2020

[The role of chemokines such as RANTES in allergic disease]

1 reference

12 December 2020

Efficacy of anti-IgE therapy in patients with atopic dermatitis

1 reference

12 December 2020

Proteinase-activated receptor-2 mediates itch: a novel pathway for pruritus in human skin.

1 reference

12 December 2020

Mast cell-associated TNF promotes dendritic cell migration

1 reference

12 December 2020

Serum eosinophil derived neurotoxin may reflect more strongly disease severity in childhood atopic dermatitis than eosinophil cationic protein

1 reference

12 December 2020

Low-dose anti-IgE therapy in patients with atopic eczema with high serum IgE levels

1 reference

12 December 2020

Exogenous and endogenous antigens are differentially presented by mast cells to CD4+ T lymphocytes

1 reference

12 December 2020

Histamine and atopic eczema.

1 reference

12 December 2020

Down-regulation of Fc(epsilon)RI expression on human basophils during in vivo treatment of atopic patients with anti-IgE antibody.

1 reference

12 December 2020

Heterogeneity of human peripheral blood eosinophil-type colonies: evidence for a common basophil-eosinophil progenitor

1 reference

12 December 2020

Effectiveness of house dust-mite allergen avoidance through clean room therapy in patients with atopic dermatitis

1 reference

12 December 2020

Double-blind controlled trial of effect of housedust-mite allergen avoidance on atopic dermatitis

1 reference

12 December 2020

Isolation of cDNA clones coding for IgE autoantigens with serum IgE from atopic dermatitis patients

1 reference

12 December 2020

IL-4 induces adherence of human eosinophils and basophils but not neutrophils to endothelium. Association with expression of VCAM-1

1 reference

12 December 2020

Aeroallergen contact can exacerbate atopic dermatitis: patch tests as a diagnostic tool

1 reference

12 December 2020

A current perspective on the role of eosinophils in dermatologic diseases

1 reference

12 December 2020

Regulation of endothelial and mesothelial cell function by interleukin-13: selective induction of vascular cell adhesion molecule-1 and amplification of interleukin-6 production

1 reference

12 December 2020

CCL1-CCR8 interactions: an axis mediating the recruitment of T cells and Langerhans-type dendritic cells to sites of atopic skin inflammation

1 reference

12 December 2020

Mast cells in atopic dermatitis

1 reference

12 December 2020

Atopic dermatitis of the face, scalp, and neck: Type I reaction to the yeast Pityrosporum ovale?

1 reference

12 December 2020

Noncytotoxic activation of neutrophils by eosinophil granule major basic protein. Effect on superoxide anion generation and lysosomal enzyme release.

1 reference

12 December 2020

Prevalence of immunoglobulin E for fungi in atopic children

1 reference

12 December 2020

Eosinophil infiltration and degranulation in normal human tissue

1 reference

12 December 2020

Staphylococcal enterotoxin-specific IgE antibodies in atopic dermatitis

1 reference

12 December 2020

A study of allergen-specific IgE antibodies in Indian patients of atopic dermatitis

1 reference

12 December 2020

Morphology of atopic eczema

1 reference

12 December 2020

Mast cells regulate IFN-gamma expression in the skin and circulating IgE levels in allergen-induced skin inflammation

1 reference

12 December 2020

A role for eosinophils in atopic dermatitis

1 reference

12 December 2020

Effectiveness of omalizumab in a patient with severe asthma and atopic dermatitis

1 reference

12 December 2020

Urinary eosinophil-derived neurotoxin concentrations in patients with atopic dermatitis: a useful clinical marker for disease activity

1 reference

12 December 2020

Dendritic cell modulation by mast cells controls the Th1/Th2 balance in responding T cells

1 reference

12 December 2020

Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/Nga mice

1 reference

12 December 2020

Urinary eosinophil protein X in children with atopic dermatitis: relation to atopy and disease activity

1 reference

12 December 2020

Heterogeneity of interleukin 5 genetic background in atopic dermatitis patients: significant difference between those with blood eosinophilia and normal eosinophil levels

1 reference

12 December 2020

Success of omalizumab as monotherapy in adult atopic dermatitis: case report and discussion of the high-affinity immunoglobulin E receptor, FcepsilonRI.

1 reference

12 December 2020

Confirmation of the association between high levels of immunoglobulin E food sensitization and eczema in infancy: an international study

1 reference

12 December 2020

Treatment of recalcitrant atopic dermatitis with omalizumab

1 reference

12 December 2020

10.1007/S12016-011-8252-4

Identifiers

DOI

1 reference

24 August 2017

1 reference

PubMed ID

21249468